| 7 |
AST-001 |
Frontiers in Pharmacology |
2024 |
Population pharmacokinetic and pharmacodynamic model guided weight-tiered dose of AST-001 in pediatric patients with autism spectrum disorder
|
| 6 |
AST-001 |
PCN |
2024 |
AST-001 versus placebo for social communication in children with autism spectrum disorder: A randomized clinical trial
|
| 5 |
AST-001 |
Biomedicines |
2023 |
AST-001 Improves Social Deficits and Restores Dopamine Neuron Activity
in a Mouse Model of Autism
|
| 4 |
AST-001 |
Appl Microsc |
2023 |
Changes of lysosome by L-Serine in rotenone-treated hippocampal neurons
|
| 3 |
AST-001 |
Int J Mol Sci. |
2022 |
Restoration of Cathepsin D Level via L-Serine Attenuates
PPA-Induced Lysosomal Dysfunction in Neuronal Cells
|
| 2 |
AST-001 |
Front Phamarcol. |
2022 |
Population Pharmacokinetic Model of AST-001, L-Isomer of Serine,
Combining Endogenous Production and Exogenous Administration
in Healthy Subjects
|
| 1 |
AST-001 |
Free Radic Biol Med. |
2019 |
L-Serine protects mouse hippocampal neuronal HT22 cells against
oxidative stress-mediated mitochondrial damage and apoptotic cell death
|